Sutureless aspiration cutter biopsy is beneficial in diagnosing ocular cancers

Article

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma.

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma, according to a paper featured in the European Journal of Ophthalmology.

Dr Paul T. Finger et al., New York Eye Cancer Center, New York, USA, included three patients in the study with orbital adnexal tumours. Each participant underwent orbital biopsy via a 3 mm incision into the eyelid or conjunctival fornix.

A bimanual technique was used to introduce standard aspiration cutters into the anterior and posterior orbital tumours. The team conducted cytopathology, histopathology and immunohistochemical analysis on all three patients.

The diagnoses were orbital lymphoma, metastatic endometrial adenocarcinoma, and metastatic prostate cancer, with the 20G aspiration cutter yielding the most tissue. The small incisions did not require any sutures.

The technique was strongly linked to fine needle aspiration biopsy, controlled aspiration and enclosed mechanical cutting.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.